1239 related articles for article (PubMed ID: 24295058)
1. Inborn errors of metabolism and expanded newborn screening: review and update.
Mak CM; Lee HC; Chan AY; Lam CW
Crit Rev Clin Lab Sci; 2013 Nov; 50(6):142-62. PubMed ID: 24295058
[TBL] [Abstract][Full Text] [Related]
2. Inborn Error of Metabolism (IEM) screening in Singapore by electrospray ionization-tandem mass spectrometry (ESI/MS/MS): An 8 year journey from pilot to current program.
Lim JS; Tan ES; John CM; Poh S; Yeo SJ; Ang JS; Adakalaisamy P; Rozalli RA; Hart C; Tan ET; Ranieri E; Rajadurai VS; Cleary MA; Goh DL
Mol Genet Metab; 2014; 113(1-2):53-61. PubMed ID: 25102806
[TBL] [Abstract][Full Text] [Related]
3. Analysis of inborn errors of metabolism: disease spectrum for expanded newborn screening in Hong Kong.
Lee HC; Mak CM; Lam CW; Yuen YP; Chan AO; Shek CC; Siu TS; Lai CK; Ching CK; Siu WK; Chen SP; Law CY; Tai HL; Tam S; Chan AY
Chin Med J (Engl); 2011 Apr; 124(7):983-9. PubMed ID: 21542954
[TBL] [Abstract][Full Text] [Related]
4. Expanded newborn screening and confirmatory follow-up testing for inborn errors of metabolism detected by tandem mass spectrometry.
Ozben T
Clin Chem Lab Med; 2013 Jan; 51(1):157-76. PubMed ID: 23183752
[TBL] [Abstract][Full Text] [Related]
5. Next generation sequencing as a follow-up test in an expanded newborn screening programme.
Smon A; Repic Lampret B; Groselj U; Zerjav Tansek M; Kovac J; Perko D; Bertok S; Battelino T; Trebusak Podkrajsek K
Clin Biochem; 2018 Feb; 52():48-55. PubMed ID: 29111448
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and therapeutic monitoring of inborn errors of metabolism in 100,077 newborns from Jining city in China.
Yang CJ; Wei N; Li M; Xie K; Li JQ; Huang CG; Xiao YS; Liu WH; Chen XG
BMC Pediatr; 2018 Mar; 18(1):110. PubMed ID: 29534692
[TBL] [Abstract][Full Text] [Related]
7. [Tandem mass spectrometry as screening for inborn errors of metabolism].
Campos H D
Rev Med Chil; 2011 Oct; 139(10):1356-64. PubMed ID: 22286738
[TBL] [Abstract][Full Text] [Related]
8. Neonatal screening for inborn errors of metabolism: cost, yield and outcome.
Pollitt RJ; Green A; McCabe CJ; Booth A; Cooper NJ; Leonard JV; Nicholl J; Nicholson P; Tunaley JR; Virdi NK
Health Technol Assess; 1997; 1(7):i-iv, 1-202. PubMed ID: 9483160
[TBL] [Abstract][Full Text] [Related]
9. Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review.
Pandor A; Eastham J; Beverley C; Chilcott J; Paisley S
Health Technol Assess; 2004 Mar; 8(12):iii, 1-121. PubMed ID: 14982654
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and long-term follow-up of infants with inborn errors of metabolism identified in an expanded screening programme.
Couce ML; Castiñeiras DE; Bóveda MD; Baña A; Cocho JA; Iglesias AJ; Colón C; Alonso-Fernández JR; Fraga JM
Mol Genet Metab; 2011 Dec; 104(4):470-5. PubMed ID: 22000754
[TBL] [Abstract][Full Text] [Related]
11. Biochemical screening of 504,049 newborns in Denmark, the Faroe Islands and Greenland--experience and development of a routine program for expanded newborn screening.
Lund AM; Hougaard DM; Simonsen H; Andresen BS; Christensen M; Dunø M; Skogstrand K; Olsen RK; Jensen UG; Cohen A; Larsen N; Saugmann-Jensen P; Gregersen N; Brandt NJ; Christensen E; Skovby F; Nørgaard-Pedersen B
Mol Genet Metab; 2012 Nov; 107(3):281-93. PubMed ID: 22795865
[TBL] [Abstract][Full Text] [Related]
12. Human biochemical genetics: an insight into inborn errors of metabolism.
Yu C; Scott CR
J Zhejiang Univ Sci B; 2006 Feb; 7(2):165-6. PubMed ID: 16421978
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic challenges of aminoacidopathies and organic acidemias in a developing country: a twelve-year experience.
Karam PE; Habbal MZ; Mikati MA; Zaatari GE; Cortas NK; Daher RT
Clin Biochem; 2013 Dec; 46(18):1787-92. PubMed ID: 23994778
[TBL] [Abstract][Full Text] [Related]
14. Policy issues related to expanded newborn screening: a review of three genetic/metabolic disorders.
Bishop Hubbard H
Policy Polit Nurs Pract; 2007 Aug; 8(3):201-9. PubMed ID: 18178927
[TBL] [Abstract][Full Text] [Related]
15. The first pilot study of expanded newborn screening for inborn errors of metabolism and survey of related knowledge and opinions of health care professionals in Hong Kong.
Mak CM; Law EC; Lee HH; Siu WK; Chow KM; Au Yeung SK; Ngan HY; Tse NK; Kwong NS; Chan GC; Lee KW; Chan WP; Wong SF; Tang MH; Kan AS; Hui AP; So PL; Shek CC; Lee RS; Wong KY; Yau EK; Poon KH; Siu S; Poon GW; Kwok AM; Ng JW; Yim VC; Ma GG; Chu CH; Tong TY; Chong YK; Chen SP; Ching CK; Chan AO; Tam S; Lau RL; Ng WF; Lee KC; Chan AY; Lam CW
Hong Kong Med J; 2018 Jun; 24(3):226-237. PubMed ID: 29888706
[TBL] [Abstract][Full Text] [Related]
16. Newborn screening of inherited metabolic disorders: the Italian situation.
Focardi M; Pinchi V; Defraia B; Gualco B; Varvara G; Norelli GA
J Biol Regul Homeost Agents; 2016; 30(3):909-914. PubMed ID: 27655520
[TBL] [Abstract][Full Text] [Related]
17. Pilot study of newborn screening of inborn error of metabolism using tandem mass spectrometry in Malaysia: outcome and challenges.
Yunus ZM; Rahman SA; Choy YS; Keng WT; Ngu LH
J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1031-9. PubMed ID: 27544719
[TBL] [Abstract][Full Text] [Related]
18. State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results.
Tarini BA; Christakis DA; Welch HG
Pediatrics; 2006 Aug; 118(2):448-56. PubMed ID: 16882794
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometry in clinical chemistry: the case of newborn screening.
la Marca G
J Pharm Biomed Anal; 2014 Dec; 101():174-82. PubMed ID: 24844843
[TBL] [Abstract][Full Text] [Related]
20. Incidence and genetic variants of inborn errors of metabolism identified through newborn screening: A 7-year study in eastern coastal areas of China.
Men S; Liu S; Zheng Q; Yang S; Mao H; Wang Z; Gu Y; Tang X; Wang L
Mol Genet Genomic Med; 2023 Jun; 11(6):e2152. PubMed ID: 36787440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
